Pricing Log in Create free account

Viking Therapeutics, Inc. (VKTX) vs Viridian Therapeutics, Inc. (VRDN)

Viking Therapeutics, Inc. and Viridian Therapeutics, Inc. are both Biotechnology companies. Viking Therapeutics, Inc. and Viridian Therapeutics, Inc. are of similar size ($3.3B and $3.2B). Viking Therapeutics, Inc. has the higher net margin (0.00% vs −1,724.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Viridian Therapeutics, Inc. leads on 8 and Viking Therapeutics, Inc. on 5.

Valuation

Metric VKTX VRDN Biotechnology median
P/E n/m n/m 10.26
P/S n/m 117.81 9.18
P/B 5.18 5.49 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales n/m 91.03 8.98
Earnings yield (20.90%) (11.73%) (34.89%)
Free cash flow yield (15.17%) (11.08%) (24.52%)

Profitability

Metric VKTX VRDN Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (1,781.38%) 0.00%
Net margin 0.00% (1,724.06%) 0.00%
Free cash flow margin 0.00% (1,305.42%) 0.00%
Return on equity (96.37%) 0.00% (50.12%)
Return on assets (73.07%) (56.49%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric VKTX VRDN Biotechnology median
Revenue growth (TTM) — (62.83%) 6.26%
EPS growth (last fiscal year) (215.84%) (8.14%) 29.88%
Revenue growth, 5-year CAGR — 132.18% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric VKTX VRDN Biotechnology median
Debt to equity 0.43 0.00 0.00
Current ratio 7.27 14.46 4.89
Net debt to EBITDA 1.76 2.23 1.01

Dividend

Metric VKTX VRDN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric VKTX VRDN Biotechnology median
Market cap 3.29b 3.23b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack